| Year |
Citation |
Score |
| 2017 |
Drancourt M, Nkamga VD, Lakhe NA, Régis JM, Dufour H, Fournier PE, Bechah Y, Scheld WM, Raoult D. Evidence of Archaeal Methanogens in Brain Abscess. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28379309 DOI: 10.1093/Cid/Cix286 |
0.325 |
|
| 2011 |
Mathers AJ, Cox HL, Kitchel B, Bonatti H, Brassinga AK, Carroll J, Scheld WM, Hazen KC, Sifri CD. Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid. Mbio. 2: e00204-11. PMID 22045989 DOI: 10.1128/Mbio.00204-11 |
0.326 |
|
| 2010 |
Quagliarello V, Scheld WM. Infectious disease: do steroids benefit patients with bacterial meningitis? Nature Reviews. Neurology. 6: 529-30. PMID 20927051 DOI: 10.1038/Nrneurol.2010.132 |
0.351 |
|
| 2010 |
Tessier JM, Scheld WM. Principles of antimicrobial therapy. Handbook of Clinical Neurology. 96: 17-29. PMID 20109672 DOI: 10.1016/S0072-9752(09)96002-X |
0.393 |
|
| 2009 |
Spellberg B, Talbot GH, Boucher HW, Bradley JS, Gilbert D, Scheld WM, Edwards J, Bartlett JG. Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 383-91. PMID 19555285 DOI: 10.1086/600296 |
0.341 |
|
| 2009 |
Al Masalma M, Armougom F, Scheld WM, Dufour H, Roche PH, Drancourt M, Raoult D. The expansion of the microbiological spectrum of brain abscesses with use of multiple 16S ribosomal DNA sequencing. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 1169-78. PMID 19335164 DOI: 10.1086/597578 |
0.334 |
|
| 2009 |
Aregawi D, Lopez D, Wick M, Scheld WM, Schiff D. Disseminated strongyloidiasis complicating glioblastoma therapy: a case report. Journal of Neuro-Oncology. 94: 439-43. PMID 19333553 DOI: 10.1007/S11060-009-9878-4 |
0.32 |
|
| 2008 |
Smith RL, Evans HL, Chong TW, McElearney ST, Hedrick TL, Swenson BR, Scheld WM, Pruett TL, Sawyer RG. Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit. Surgical Infections. 9: 423-31. PMID 18759679 DOI: 10.1089/Sur.2007.024 |
0.31 |
|
| 2008 |
Hedrick TL, Schulman AS, McElearney ST, Smith RL, Swenson BR, Evans HL, Truwit JD, Scheld WM, Sawyer RG. Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen. Surgical Infections. 9: 139-52. PMID 18426346 DOI: 10.1089/Sur.2006.102 |
0.316 |
|
| 2008 |
Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 155-64. PMID 18171244 DOI: 10.1086/524891 |
0.333 |
|
| 2005 |
Fulnecky EJ, Wright D, Scheld WM, Kanawati L, Shoham S. Amikacin and colistin for treatment of Acinetobacter baumannii meningitis. The Journal of Infection. 51: e249-51. PMID 15913780 DOI: 10.1016/J.Jinf.2005.04.003 |
0.33 |
|
| 2005 |
Ivey NS, Martin EN, Scheld WM, Nathan BR. A new method for measuring blood-brain barrier permeability demonstrated with Europium-bound albumin during experimental lipopolysaccharide (LPS) induced meningitis in the rat. Journal of Neuroscience Methods. 142: 91-5. PMID 15652621 DOI: 10.1016/J.Jneumeth.2004.07.015 |
0.643 |
|
| 2004 |
Sullivan GW, Fang G, Linden J, Scheld WM. A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. The Journal of Infectious Diseases. 189: 1897-904. PMID 15122527 DOI: 10.1086/386311 |
0.313 |
|
| 2004 |
Cohen SB, Gill SS, Baer GS, Leo BM, Scheld WM, Diduch DR. Reducing joint destruction due to septic arthrosis using an adenosine2A receptor agonist. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 22: 427-35. PMID 15013106 DOI: 10.1016/J.Orthres.2003.08.011 |
0.335 |
|
| 2003 |
Scheld WM. Whipple disease of the central nervous system. The Journal of Infectious Diseases. 188: 797-800. PMID 12964109 DOI: 10.1086/378075 |
0.348 |
|
| 2003 |
Nathan BR, Scheld WM. The efficacy of trovafloxacin versus ceftriaxone in the treatment of experimental brain abscess/cerebritis in the rat. Life Sciences. 73: 1773-82. PMID 12888116 DOI: 10.1016/S0024-3205(03)00507-1 |
0.376 |
|
| 2003 |
Owusu-Ofori A, Scheld WM. Treatment of Salmonella meningitis: two case reports and a review of the literature. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 7: 53-60. PMID 12718811 DOI: 10.1016/S1201-9712(03)90043-9 |
0.326 |
|
| 2003 |
Scheld WM. Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerging Infectious Diseases. 9: 1-9. PMID 12533274 DOI: 10.3201/Eid0901.020277 |
0.324 |
|
| 2002 |
Tunkel AR, Scheld WM. Corticosteroids for everyone with meningitis? The New England Journal of Medicine. 347: 1613-5. PMID 12432049 DOI: 10.1056/Nejme020131 |
0.325 |
|
| 2002 |
Scheld WM, Koedel U, Nathan B, Pfister HW. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. The Journal of Infectious Diseases. 186: S225-33. PMID 12424702 DOI: 10.1086/344939 |
0.314 |
|
| 2002 |
Tunkel AR, Scheld WM. Treatment of Bacterial Meningitis. Current Infectious Disease Reports. 4: 7-16. PMID 11853652 DOI: 10.1007/S11908-002-0062-7 |
0.373 |
|
| 2001 |
Hogan CJ, Fang GD, Scheld WM, Linden J, Diduch DR. Inhibiting the inflammatory response in joint sepsis. Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 17: 311-315. PMID 11239354 DOI: 10.1053/Jars.2001.21492 |
0.327 |
|
| 1999 |
Kesser BW, Hashisaki GT, Spindel JH, Ruth RA, Scheld WM. Time course of hearing loss in an animal model of pneumococcal meningitis. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 120: 628-37. PMID 10229585 DOI: 10.1053/Hn.1999.V120.A92772 |
0.315 |
|
| 1997 |
Anglim AM, Klym B, Byers KE, Scheld WM, Farr BM. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Archives of Internal Medicine. 157: 1132-6. PMID 9164379 DOI: 10.1001/Archinte.1997.00440310098010 |
0.308 |
|
| 1996 |
Townsend GC, Scheld WM. The use of corticosteroids in the management of bacterial meningitis in adults. The Journal of Antimicrobial Chemotherapy. 37: 1051-61. PMID 8836809 DOI: 10.1093/Jac/37.6.1051 |
0.356 |
|
| 1996 |
Townsend GC, Scheld WM. Anti-Inflammatory Therapy for Bacterial Meningitis Clinical Immunotherapeutics. 5: 223-229. DOI: 10.1007/Bf03259085 |
0.357 |
|
| 1995 |
Townsend GC, Scheld WM. In vitro models of the blood-brain barrier to study bacterial meningitis. Trends in Microbiology. 3: 441-5. PMID 8574519 DOI: 10.1016/S0966-842X(00)88999-4 |
0.331 |
|
| 1995 |
Townsend GC, Scheld WM. CLINICALLY IMPORTANT TRENDS IN BACTERIAL MENINGITIS Infectious Diseases in Clinical Practice. 4: 423-430. DOI: 10.1097/00019048-199511000-00011 |
0.309 |
|
| 1993 |
Tunkel AR, Scheld WM. Pathogenesis and pathophysiology of bacterial meningitis. Clinical Microbiology Reviews. 6: 118-36. PMID 8472245 |
0.308 |
|
| 1993 |
Townsend GC, Scheld WM. Adjunctive therapy for bacterial meningitis: rationale for use, current status, and prospects for the future. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 17: S537-49. PMID 8274621 DOI: 10.1093/Clinids/17.Supplement_2.S537 |
0.379 |
|
| 1992 |
Quagliarello V, Scheld WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. The New England Journal of Medicine. 327: 864-72. PMID 1508247 DOI: 10.1056/Nejm199209173271208 |
0.364 |
|
| 1991 |
Tunkel AR, Scheld WM. Therapy of bacterial meningitis in children. International Journal of Antimicrobial Agents. 1: 109-115. PMID 18611496 DOI: 10.1016/0924-8579(91)90004-W |
0.392 |
|
| 1991 |
Scheld WM, Mandell GL. Nosocomial pneumonia: pathogenesis and recent advances in diagnosis and therapy. Reviews of Infectious Diseases. 13: S743-51. PMID 1925319 DOI: 10.1093/Clinids/13.Supplement_9.S743 |
0.352 |
|
| 1991 |
Tunkel AR, Rosser SW, Hansen EJ, Scheld WM. Blood-brain barrier alterations in bacterial meningitis: development of an in vitro model and observations on the effects of lipopolysaccharide. In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association. 27: 113-20. PMID 1826902 DOI: 10.1007/Bf02630996 |
0.334 |
|
| 1991 |
Tunkel AR, Scheld WM. Acute therapy of bacterial meningitis Journal of Intensive Care Medicine. 6: 229-237. DOI: 10.1177/088506669100600502 |
0.363 |
|
| 1989 |
Tunkel AR, Scheld WM. Therapy of bacterial meningitis: principles and practice. Infection Control and Hospital Epidemiology. 10: 565-9. PMID 2693533 DOI: 10.2307/30144239 |
0.363 |
|
| 1989 |
Scheld WM. Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system. Reviews of Infectious Diseases. 11: S1669-90. PMID 2690302 DOI: 10.1093/Clinids/11.Supplement_7.S1669 |
0.305 |
|
| 1989 |
Scheld WM. Quinolone therapy for infections of the central nervous system. Reviews of Infectious Diseases. 11: S1194-202. PMID 2672249 DOI: 10.1093/Clinids/11.Supplement_5.S1194 |
0.374 |
|
| 1989 |
Tunkel AR, Scheld WM. Alterations of the blood-brain barrier in bacterial meningitis: in vivo and in vitro models. The Pediatric Infectious Disease Journal. 8: 911-3. PMID 2626303 DOI: 10.1097/00006454-198912000-00040 |
0.332 |
|
| 1987 |
Scheld WM. Therapy of streptococcal endocarditis: correlation of animal model and clinical studies. The Journal of Antimicrobial Chemotherapy. 20: 71-85. PMID 3316165 DOI: 10.1093/Jac/20.Suppl_A.71 |
0.333 |
|
| 1986 |
Howard MA, Grady MS, Park TS, Scheld WM. Pharmacokinetics of intraventricular vancomycin in hydrocephalic rats. Neurosurgery. 18: 725-9. PMID 3736800 DOI: 10.1007/978-3-662-11149-9_59 |
0.314 |
|
| 1986 |
Quagliarello VJ, Scheld WM. Recent advances in the pathogenesis and pathophysiology of bacterial meningitis. The American Journal of the Medical Sciences. 292: 306-9. PMID 3535498 DOI: 10.1097/00000441-198611000-00010 |
0.382 |
|
| 1985 |
Scheld WM, Strunk RW, Balian G, Calderone RA. Microbial adhesion to fibronectin in vitro correlates with production of endocarditis in rabbits. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 180: 474-82. PMID 3936047 DOI: 10.3181/00379727-180-42205 |
0.329 |
|
| 1985 |
Scheld WM, Brodeur JP, Foresman PA, Gratz JC, Rodeheaver GT. Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritis. Reviews of Infectious Diseases. 7: S635-47. PMID 3909319 DOI: 10.1093/Clinids/7.Supplement_4.S635 |
0.37 |
|
| 1985 |
Salata RA, Gebhart RL, Palmer DL, Wade BH, Scheld WM, Groschel DH, Wenzel RP, Mandell GL, Duma RJ. Pneumonia treated with imipenem/cilastatin. The American Journal of Medicine. 78: 104-9. PMID 3859208 DOI: 10.1016/0002-9343(85)90110-X |
0.382 |
|
| 1984 |
Scheld WM, Mandell GL. Enigmatic enterococcal endocarditis. Annals of Internal Medicine. 100: 904-5. PMID 6426360 DOI: 10.7326/0003-4819-100-6-904 |
0.302 |
|
| 1984 |
Scheld WM. Bacterial meningitis in the patient at risk: intrinsic risk factors and host defense mechanisms. The American Journal of Medicine. 76: 193-207. PMID 6372470 DOI: 10.1016/0002-9343(84)90265-1 |
0.37 |
|
| 1984 |
Scheld WM, Mandell GL. Landmark perspective. Sulfonamides and meningitis. Jama. 251: 791-4. PMID 6363730 DOI: 10.1001/Jama.1984.03340300083036 |
0.33 |
|
| 1983 |
Scheld WM, Sande MA. Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. The Journal of Clinical Investigation. 71: 411-9. PMID 6826714 DOI: 10.1172/Jci110785 |
0.349 |
|
| 1983 |
Scheld WM, Keeley JM. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis. The Journal of Antimicrobial Chemotherapy. 12: 65-78. PMID 6421794 DOI: 10.1093/Jac/12.Suppl_D.65 |
0.334 |
|
| 1983 |
Scheld WM. Evaluation of rifampin and other antibiotics against Listeria monocytogenes in vitro and in vivo. Reviews of Infectious Diseases. 5: S593-9. PMID 6415782 DOI: 10.1093/Clinids/5.Supplement_3.S593 |
0.362 |
|
| 1981 |
Sande MA, Korzeniowski OM, Allegro GM, Brennan RO, Zak O, Scheld WM. Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Reviews of Infectious Diseases. 3: 98-109. PMID 7221361 DOI: 10.1093/Clinids/3.1.98 |
0.338 |
|
| 1981 |
Scheld WM. Pathophysiological correlates in bacterial meningitis. The Journal of Infection. 3: 5-19. PMID 6764490 DOI: 10.1016/S0163-4453(81)80003-5 |
0.31 |
|
| 1980 |
Sande MA, Scheld WM. Combination antibiotic therapy of bacterial endocarditis. Annals of Internal Medicine. 92: 390-5. PMID 6986829 DOI: 10.7326/0003-4819-92-3-390 |
0.336 |
|
| 1979 |
Scheld WM, Fletcher DD, Fink FN, Sande MA. Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. The Journal of Infectious Diseases. 140: 287-94. PMID 115932 DOI: 10.1093/Infdis/140.3.287 |
0.366 |
|
| Show low-probability matches. |